• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections.从生理学到药理学:复发性尿路感染的发病机制和治疗的进展。
Curr Urol Rep. 2013 Oct;14(5):448-56. doi: 10.1007/s11934-013-0354-5.
2
Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial.全科医生提供的标准化中草药治疗与中医师提供的个体化治疗对复发性尿路感染女性的疗效比较:一项随机对照试验的研究方案
Trials. 2016 Jul 27;17:358. doi: 10.1186/s13063-016-1471-5.
3
Pharmacotherapeutic advances for recurrent urinary tract infections in women.女性复发性尿路感染的药物治疗进展。
Expert Opin Pharmacother. 2020 Nov;21(16):2011-2026. doi: 10.1080/14656566.2020.1795128. Epub 2020 Jul 27.
4
Recurrent UTI in Women-Risk Factors and Management.女性复发性尿路感染——危险因素与管理。
Infect Dis Clin North Am. 2024 Jun;38(2):325-341. doi: 10.1016/j.idc.2024.03.010. Epub 2024 Apr 10.
5
Evidence of bladder oversensitivity in the absence of an infection in premenopausal women with a history of recurrent urinary tract infections.绝经前有反复尿路感染史的女性,在没有感染的情况下存在膀胱过度敏感的证据。
BJU Int. 2012 Jul;110(2):247-51. doi: 10.1111/j.1464-410X.2011.10766.x. Epub 2011 Nov 30.
6
Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.大肠杆菌引起复发性尿路感染的重要细菌特征。
Dan Med Bull. 2011 Apr;58(4):B4187.
7
Consumption of sweetened, dried cranberries may reduce urinary tract infection incidence in susceptible women--a modified observational study.食用加糖、干燥的蔓越莓可能会降低易感女性尿路感染的发生率——一项改良的观察性研究。
Nutr J. 2013 Oct 18;12(1):139. doi: 10.1186/1475-2891-12-139.
8
First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine Uromune.在英国首次使用细菌疫苗Uromune治疗复发性尿路感染女性的经验。
BJU Int. 2018 Feb;121(2):289-292. doi: 10.1111/bju.14067. Epub 2017 Nov 23.
9
Chronic urinary tract infections in patients with spinal cord lesions - biofilm infection with need for long-term antibiotic treatment.脊髓损伤患者的慢性尿路感染——生物膜感染,需要长期抗生素治疗。
APMIS. 2017 Apr;125(4):385-391. doi: 10.1111/apm.12685.
10
Management of uncomplicated recurrent urinary tract infections.单纯性复发性尿路感染的管理。
BJU Int. 2022 Jun;129(6):668-678. doi: 10.1111/bju.15630. Epub 2021 Nov 17.

引用本文的文献

1
Uropathogenic Escherichia coli (UPEC) that hides its identity: features of LC2 and EC73 strains from recurrent urinary tract infections.隐匿身份的尿路致病性大肠杆菌(UPEC):来自复发性尿路感染的LC2和EC73菌株的特征
BMC Microbiol. 2025 Aug 25;25(1):547. doi: 10.1186/s12866-025-04287-8.
2
Two-component system GrpP/GrpQ promotes pathogenicity of uropathogenic Escherichia coli CFT073 by upregulating type 1 fimbria.双组分系统GrpP/GrpQ通过上调1型菌毛促进尿路致病性大肠杆菌CFT073的致病性。
Nat Commun. 2025 Jan 11;16(1):607. doi: 10.1038/s41467-025-55982-z.
3
Imidazolium, pyridinium and pyrazinium based ionic liquids with octyl side chains as potential antibacterial agents against multidrug resistant uropathogenic .具有辛基侧链的咪唑鎓、吡啶鎓和吡嗪鎓基离子液体作为抗多重耐药性尿路致病性细菌的潜在抗菌剂。
Heliyon. 2024 Oct 24;10(22):e39829. doi: 10.1016/j.heliyon.2024.e39829. eCollection 2024 Nov 30.
4
Urinary tract infections: a retrospective cohort study of (mis)matching antimicrobial therapy and clinical outcome among Finnish adults.尿路感染:芬兰成年人中抗菌治疗与临床结果(不)匹配的回顾性队列研究。
JAC Antimicrob Resist. 2024 Nov 26;6(6):dlae188. doi: 10.1093/jacamr/dlae188. eCollection 2024 Dec.
5
Clinical characteristics and nomogram model for predicting the risk of recurrence of complicated urinary tract infection in pediatric patients.预测小儿复杂性尿路感染复发风险的临床特征和列线图模型。
Sci Rep. 2024 Oct 25;14(1):25393. doi: 10.1038/s41598-024-76901-0.
6
A cynomolgus monkey urinary tract infection model confirms efficacy of new FimH vaccine candidates.食蟹猴尿路感染模型证实新型 FimH 疫苗候选物的有效性。
Infect Immun. 2024 Oct 15;92(10):e0016924. doi: 10.1128/iai.00169-24. Epub 2024 Sep 19.
7
Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics.尿路感染:发病机制、宿主易感性及新出现的治疗方法。
Nat Rev Microbiol. 2025 Feb;23(2):72-86. doi: 10.1038/s41579-024-01092-4. Epub 2024 Sep 9.
8
Role of N-acetylkynurenine in mediating the effect of gut microbiota on urinary tract infection: a Mendelian randomization study.N-乙酰犬尿氨酸在介导肠道微生物群对尿路感染影响中的作用:一项孟德尔随机化研究
Front Microbiol. 2024 Apr 22;15:1384095. doi: 10.3389/fmicb.2024.1384095. eCollection 2024.
9
Case report: Long-term follow-up of patients who received a FimCH vaccine for prevention of recurrent urinary tract infections caused by antibiotic resistant Enterobacteriaceae: a case report series.病例报告:接受 FimCH 疫苗预防抗生素耐药肠杆菌科引起的复发性尿路感染的患者的长期随访:病例系列报告。
Front Immunol. 2024 Mar 13;15:1359738. doi: 10.3389/fimmu.2024.1359738. eCollection 2024.
10
Urinary Tract Infections Caused by Uropathogenic : Mechanisms of Infection and Treatment Options.尿路感染的病原体:感染机制和治疗选择。
Int J Mol Sci. 2023 Jun 23;24(13):10537. doi: 10.3390/ijms241310537.

本文引用的文献

1
Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection.从复发性尿路感染女性的肠道和尿路中分离出的大肠杆菌菌株的基因组多样性和适应性。
Sci Transl Med. 2013 May 8;5(184):184ra60. doi: 10.1126/scitranslmed.3005497.
2
Urine post equivalent daily cranberry juice consumption may opsonize uropathogenicity of Escherichia coli.尿液中相当于每日蔓越莓汁摄入量的物质可能调理大肠埃希菌的尿路致病性。
J Infect Chemother. 2013 Oct;19(5):812-7. doi: 10.1007/s10156-013-0565-1. Epub 2013 Feb 26.
3
The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli.Cpx 应激反应系统增强了尿路致病性大肠杆菌的适应性和毒力。
Infect Immun. 2013 May;81(5):1450-9. doi: 10.1128/IAI.01213-12. Epub 2013 Feb 19.
4
RpoS contributes to phagocyte oxidase-mediated stress resistance during urinary tract infection by Escherichia coli CFT073.RpoS 有助于大肠埃希菌 CFT073 引起的尿路感染期间吞噬细胞氧化酶介导的应激抵抗。
mBio. 2013 Feb 12;4(1):e00023-13. doi: 10.1128/mBio.00023-13.
5
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.产超广谱β-内酰胺酶大肠埃希菌尿分离株中环丙沙星耐药率的增加。
World J Urol. 2013 Dec;31(6):1427-32. doi: 10.1007/s00345-013-1031-5. Epub 2013 Jan 29.
6
Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model.雌激素对绝经后小鼠尿路感染大肠杆菌发病机制的调节作用。
Infect Immun. 2013 Mar;81(3):733-9. doi: 10.1128/IAI.01234-12. Epub 2012 Dec 21.
7
Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli.评估与尿道致病性大肠埃希菌 FimH 黏附素融合的鞭毛蛋白(FliC)的免疫反应。
Mol Immunol. 2013 May;54(1):32-9. doi: 10.1016/j.molimm.2012.11.002. Epub 2012 Dec 3.
8
OmpR regulation of the uropathogenic Escherichia coli fimB gene in an acidic/high osmolality environment.酸性/高渗透压环境中 OmpR 对尿路致病性大肠杆菌 fimB 基因的调控。
Microbiology (Reading). 2013 Feb;159(Pt 2):316-327. doi: 10.1099/mic.0.059386-0. Epub 2012 Nov 22.
9
Adenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli.腺苷酸环化酶和环 AMP 受体蛋白调节尿路致病性大肠杆菌的应激抗性和毒力。
Infect Immun. 2013 Jan;81(1):249-58. doi: 10.1128/IAI.00796-12. Epub 2012 Oct 31.
10
Target Selectivity of FimH Antagonists.FimH 拮抗剂的靶标选择性。
J Med Chem. 2012 Nov 26;55(22):9810-6. doi: 10.1021/jm3010338. Epub 2012 Nov 1.

从生理学到药理学:复发性尿路感染的发病机制和治疗的进展。

From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections.

机构信息

Department of Molecular Microbiology and Microbial Pathogenesis; Center for Women's Infectious Disease Research, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8230, Saint Louis, MO, 63110, USA.

出版信息

Curr Urol Rep. 2013 Oct;14(5):448-56. doi: 10.1007/s11934-013-0354-5.

DOI:10.1007/s11934-013-0354-5
PMID:23832844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3797163/
Abstract

Urinary tract infections (UTIs) are common, and over half of women report having had at least one in their lifetime. Nearly a third of these women experience recurrent UTI episodes, but the mechanisms of these recurrences are not fully elucidated. Frequent use of antimicrobials for treatment and prevention of UTIs and other infections has contributed to the evolution of multidrug-resistant microorganisms globally. This is a looming worldwide crisis that has created an urgent need for novel strategies for the treatment and prevention of UTIs. Furthering our understanding of the mechanisms of recurrent UTIs, from both host and bacterial perspectives, will be paramount in developing targeted management strategies. In this review, we discuss recent findings regarding recurrent UTIs in women, including progress in our understanding of the mechanisms of recurrence as well as emerging treatments.

摘要

尿路感染(UTIs)很常见,超过一半的女性报告一生中至少患过一次。这些女性中有近三分之一经历过复发性尿路感染发作,但这些复发的机制尚未完全阐明。频繁使用抗生素治疗和预防尿路感染和其他感染导致了全球多药耐药微生物的进化。这是一场迫在眉睫的全球危机,迫切需要新的策略来治疗和预防尿路感染。从宿主和细菌两个方面进一步了解复发性尿路感染的机制对于制定有针对性的管理策略至关重要。在这篇综述中,我们讨论了女性复发性尿路感染的最新发现,包括我们对复发机制的理解以及新出现的治疗方法的进展。